Trident Lifeline Share Price Today

Trident Lifeline Q2FY27 Results: Net profit rises 33% YoY to ₹6.6 crore

Consolidated revenue rose 50% YoY to ₹47.1 crore, driven by a 183% surge in medical devices segment. Standalone net profit increased 33.1% YoY to ₹6.6 crore, with standalone EBITDA margin expanding 653 bps to 29.8%. Board declared an interim dividend of ₹0.50 per share with a record date of October 30, 2026. Capacity utilization improved to 46% in Q2FY27 from 32% in Q2FY26, supporting operating leverage.

Trident Lifeline EGM passes all three resolutions with 100% votes in favour

All three special resolutions at Trident Lifeline's EGM on October 27, 2026 were passed unanimously. A total of 7,220,880 votes were cast in favour across each resolution, representing 60.39% of total outstanding shares of 11,957,000. Promoter and promoter group polled 86.84% of their 7,468,400 shares, all in favour; public non-institutions polled 17.07% of their 4,309,800 shares, all in favour. The three resolutions covered alteration of Articles of Association, preferential issue of equity shares, and preferential issue of warrants convertible into equity shares. CS Mehul Amareliya of Amareliya & Associates confirmed all resolutions were passed with the requisite majority in the Consolidated Scrutinizer's Report dated October 28, 2026.

Trident Lifeline issues corrigendum to EGM notice for Oct 27 meeting

Trident Lifeline issued a corrigendum to its EGM notice dated October 5, 2026, ahead of the October 27 meeting. The update rectifies incorrect UBO details for allottee Fincos Technology Solutions Private Limited. Fund utilization plan for ₹4,113.93 lakh equity issue clarified for working capital and subsidiary investments. Board meeting on October 16, 2026, approved amendments following BSE observations.

Trident Lifeline stake in subsidiary Mediquip falls to 58.23%

Trident Lifeline's stake in Trident Mediquip dropped to 58.23% from 59.67%. Private placement to related parties triggered the dilution of holding. Subsidiary turnover rose to ₹27.31 crore in FY26 from ₹21.29 crore in FY25. Transaction classified as a related party deal conducted at arm's length.

Trident Lifeline EGM notice details ₹58 crore preferential issue

Trident Lifeline schedules EGM on Oct 27 to approve ₹58 crore preferential issue. Equity shares of ₹41.14 crore offered to public category investors only. Warrants worth ₹16.84 crore issued to promoters and select public investors. Issue price fixed at ₹336.60 per unit based on 90-day VWAP floor price.

Trident Lifeline hosts analyst meet in Surat, discusses growth plans

Trident Lifeline Limited held an analyst meet on October 1, 2026. Meeting occurred in physical mode at Vapi and Surat venues. Management discussed growth plans and manufacturing facilities. No Unpublished Price Sensitive Information was disclosed.